X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update

Go back to X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: XFOR) Delayed: 4.00 +0.12 (3.09%)
Previous Close $3.88    52 Week High
Open $3.93    52 Week Low
Day High $4.02    P/E N/A 
Day Low $3.90    EPS
Volume 501,549